- Main
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype
- Adams, Paul;
- Altes, Albert;
- Brissot, Pierre;
- Butzeck, Barbara;
- Cabantchik, Ioav;
- Cançado, Rodolfo;
- Distante, Sonia;
- Evans, Patricia;
- Evans, Robert;
- Ganz, Tomas;
- Girelli, Domenico;
- Hultcrantz, Rolf;
- McLaren, Gordon;
- Marris, Ben;
- Milman, Nils;
- Nemeth, Elizabeta;
- Nielsen, Peter;
- Pineau, Brigitte;
- Piperno, Alberto;
- Porto, Graça;
- Prince, Dianne;
- Ryan, John;
- Sanchez, Mayka;
- Santos, Paulo;
- Swinkels, Dorine;
- Teixeira, Emerência;
- Toska, Ketil;
- Vanclooster, Annick;
- White, Desley;
- Contributors and Hemochromatosis International Taskforce
- et al.
Published Web Location
https://doi.org/10.1007/s12072-018-9855-0Abstract
Although guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-